J. Mel Sorensen
2020
In 2020, J. Mel Sorensen earned a total compensation of $3M as President and Chief Executive Officer at Galera Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $345,155 |
|---|---|
| Option Awards | $2,055,977 |
| Salary | $545,700 |
| Other | $11,400 |
| Total | $2,958,232 |
Sorensen received $2.1M in option awards, accounting for 70% of the total pay in 2020.
Sorensen also received $345.2K in non-equity incentive plan, $545.7K in salary and $11.4K in other compensation.
Rankings
In 2020, J. Mel Sorensen's compensation ranked 3,908th out of 13,090 executives tracked by ExecPay. In other words, Sorensen earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,908 out of 13,090 | 70th |
Division Manufacturing | 1,556 out of 5,624 | 72nd |
Major group Chemicals And Allied Products | 588 out of 2,257 | 74th |
Industry group Drugs | 506 out of 1,957 | 74th |
Industry Pharmaceutical Preparations | 383 out of 1,462 | 74th |
Source: SEC filing on April 28, 2022.
Sorensen's colleagues
We found one more compensation record of an executive who worked with J. Mel Sorensen at Galera Therapeutics in 2020.
2020
Christopher Degnan
Galera Therapeutics
Chief Financial Officer
News
Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
January 24, 2025
Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
April 27, 2023
Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
April 28, 2022
Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
April 27, 2020